Table 5.
Biomarkers risk discrimination for AKI progression and death
Urine Biomarker | AUC | Cutoff | Sensitivity | Specificity | Positive Likelihood Ratio | Negative Likelihood Ratio |
---|---|---|---|---|---|---|
Tubular injury marker | ||||||
NGAL (ng/ml) | 0.77 (0.68–0.85) | 287 | 0.62 | 0.85 | 4.18 | 0.45 |
IL-18 (pg/ml) | 0.71 (0.61–0.81) | 55 | 0.64 | 0.75 | 2.54 | 0.48 |
KIM-1 (ng/ml) | 0.66 (0.56–0.76) | 3.3 | 0.90 | 0.38 | 1.45 | 0.27 |
L-FABP (ng/ml) | 0.76 (0.66–0.85) | 21 | 0.67 | 0.81 | 3.52 | 0.41 |
Tubular function marker | ||||||
FENa (%) | 0.50 (0.39–0.61) | 0.10 | 0.92 | 0.20 | 1.16 | 0.40 |
Glomerular injury marker | ||||||
Albumin (mg/dl) | 0.73 (0.64–0.82) | 41 | 0.79 | 0.66 | 2.32 | 0.32 |
AUC, area under the receiver operating curve.